Sera Prognostics (NASDAQ:SERA – Get Rating) and Burning Rock Biotech (NASDAQ:BNR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation. Institutional and Insider Ownership 63.2% of Sera Prognostics […]